Reducing diabetics’ risk of Alzheimer’s and dementia

High blood sugar levels in diabetics produce more enzymes called MAPK kinases, leading to early brain cell death. Hebrew University of Jerusalem researchers have developed a peptide TXM-CB3 that in laboratory tests prevents the MAPK kinases from activating.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *